368 related articles for article (PubMed ID: 33022221)
1. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Kramer I; Hooning MJ; Mavaddat N; Hauptmann M; Keeman R; Steyerberg EW; Giardiello D; Antoniou AC; Pharoah PDP; Canisius S; Abu-Ful Z; Andrulis IL; Anton-Culver H; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Brauch H; Bremer M; Brucker SY; Burwinkel B; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Collée JM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Evans DG; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Giles GG; Goldgar DE; González-Neira A; Haiman CA; Håkansson N; Hamann U; Hartman M; Heemskerk-Gerritsen BAM; Hollestelle A; Hopper JL; Hou MF; Howell A; ; ; Ito H; Jakimovska M; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kets CM; Khusnutdinova E; Ko YD; Kristensen VN; Kurian AW; Kwong A; Lambrechts D; Le Marchand L; Li J; Lindblom A; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Matsuo K; Mavroudis D; Meindl A; Milne RL; Mulligan AM; Muranen TA; Neuhausen SL; Nevanlinna H; Newman WG; Olshan AF; Olson JE; Olsson H; Park-Simon TW; Peto J; Petridis C; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Radice P; Rennert G; Romero A; Roylance R; Saloustros E; Sawyer EJ; Schmutzler RK; Schwentner L; Scott C; See MH; Shah M; Shen CY; Shu XO; Siesling S; Slager S; Sohn C; Southey MC; Spinelli JJ; Stone J; Tapper WJ; Tengström M; Teo SH; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Vachon CM; van Ongeval C; van Veen EM; Winqvist R; Wolk A; Zheng W; Ziogas A; Easton DF; Hall P; Schmidt MK
Am J Hum Genet; 2020 Nov; 107(5):837-848. PubMed ID: 33022221
[TBL] [Abstract][Full Text] [Related]
2. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Lakeman IMM; van den Broek AJ; Vos JAM; Barnes DR; Adlard J; Andrulis IL; Arason A; Arnold N; Arun BK; Balmaña J; Barrowdale D; Benitez J; Borg A; Caldés T; Caligo MA; Chung WK; Claes KBM; ; ; Collée JM; Couch FJ; Daly MB; Dennis J; Dhawan M; Domchek SM; Eeles R; Engel C; Evans DG; Feliubadaló L; Foretova L; Friedman E; Frost D; Ganz PA; Garber J; Gayther SA; Gerdes AM; Godwin AK; Goldgar DE; Hahnen E; Hake CR; Hamann U; Hogervorst FBL; Hooning MJ; Hopper JL; Hulick PJ; Imyanitov EN; ; ; ; Isaacs C; Izatt L; Jakubowska A; James PA; Janavicius R; Jensen UB; Jiao Y; John EM; Joseph V; Karlan BY; Kets CM; Konstantopoulou I; Kwong A; Legrand C; Leslie G; Lesueur F; Loud JT; Lubiński J; Manoukian S; McGuffog L; Miller A; Gomes DM; Montagna M; Mouret-Fourme E; Nathanson KL; Neuhausen SL; Nevanlinna H; Yie JNY; Olah E; Olopade OI; Park SK; Parsons MT; Peterlongo P; Piedmonte M; Radice P; Rantala J; Rennert G; Risch HA; Schmutzler RK; Sharma P; Simard J; Singer CF; Stadler Z; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teo SH; Teulé A; Thomassen M; Thull DL; Tischkowitz M; Toland AE; Tung N; van Rensburg EJ; Vega A; Wappenschmidt B; Devilee P; van Asperen CJ; Bernstein JL; Offit K; Easton DF; Rookus MA; Chenevix-Trench G; Antoniou AC; Robson M; Schmidt MK
Genet Med; 2021 Sep; 23(9):1726-1737. PubMed ID: 34113011
[TBL] [Abstract][Full Text] [Related]
3. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.
Lopes Cardozo JMN; Andrulis IL; Bojesen SE; Dörk T; Eccles DM; Fasching PA; Hooning MJ; Keeman R; Nevanlinna H; Rutgers EJT; Easton DF; Hall P; Pharoah PDP; van 't Veer LJ; Schmidt MK;
J Clin Oncol; 2023 Apr; 41(10):1849-1863. PubMed ID: 36689693
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
5. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
7. Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.
Minnier J; Rajeevan N; Gao L; Park B; Pyarajan S; Spellman P; Haskell SG; Brandt CA; Luoh SW
JCO Precis Oncol; 2021 Jul; 5():. PubMed ID: 34381935
[TBL] [Abstract][Full Text] [Related]
8. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
9. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.
Kapoor PM; Mavaddat N; Choudhury PP; Wilcox AN; Lindström S; Behrens S; Michailidou K; Dennis J; Bolla MK; Wang Q; Jung A; Abu-Ful Z; Ahearn T; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Auer PL; Freeman LEB; Becher H; Beckmann MW; Beeghly-Fadiel A; Benitez J; Bernstein L; Bojesen SE; Brauch H; Brenner H; Brüning T; Cai Q; Campa D; Canzian F; Carracedo A; Carter BD; Castelao JE; Chanock SJ; Chatterjee N; Chenevix-Trench G; Clarke CL; Couch FJ; Cox A; Cross SS; Czene K; Dai JY; Earp HS; Ekici AB; Eliassen AH; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fritschi L; Gabrielson M; Gago-Dominguez M; Gao C; Gapstur SM; Gaudet MM; Giles GG; González-Neira A; Guénel P; Haeberle L; Haiman CA; Håkansson N; Hall P; Hamann U; Hatse S; Heyworth J; Holleczek B; Hoover RN; Hopper JL; Howell A; Hunter DJ; ; ; John EM; Jones ME; Kaaks R; Keeman R; Kitahara CM; Ko YD; Koutros S; Kurian AW; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Linet M; Lissowska J; Llaneza A; MacInnis RJ; Martinez ME; Maurer T; McLean C; Neuhausen SL; Newman WG; Norman A; O'Brien KM; Olshan AF; Olson JE; Olsson H; Orr N; Perou CM; Pita G; Polley EC; Prentice RL; Rennert G; Rennert HS; Ruddy KJ; Sandler DP; Saunders C; Schoemaker MJ; Schöttker B; Schumacher F; Scott C; Scott RJ; Shu XO; Smeets A; Southey MC; Spinelli JJ; Stone J; Swerdlow AJ; Tamimi RM; Taylor JA; Troester MA; Vachon CM; van Veen EM; Wang X; Weinberg CR; Weltens C; Willett W; Winham SJ; Wolk A; Yang XR; Zheng W; Ziogas A; Dunning AM; Pharoah PDP; Schmidt MK; Kraft P; Easton DF; Milne RL; García-Closas M; Chang-Claude J
J Natl Cancer Inst; 2021 Mar; 113(3):329-337. PubMed ID: 32359158
[TBL] [Abstract][Full Text] [Related]
10. Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort.
Lakeman IMM; Rodríguez-Girondo M; Lee A; Ruiter R; Stricker BH; Wijnant SRA; Kavousi M; Antoniou AC; Schmidt MK; Uitterlinden AG; van Rooij J; Devilee P
Genet Med; 2020 Nov; 22(11):1803-1811. PubMed ID: 32624571
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry.
Du Z; Gao G; Adedokun B; Ahearn T; Lunetta KL; Zirpoli G; Troester MA; Ruiz-Narváez EA; Haddad SA; PalChoudhury P; Figueroa J; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Mancuso N; Press MF; Deming SL; Rodriguez-Gil JL; Yao S; Ogundiran TO; Ojengbe O; Bolla MK; Dennis J; Dunning AM; Easton DF; Michailidou K; Pharoah PDP; Sandler DP; Taylor JA; Wang Q; Weinberg CR; Kitahara CM; Blot W; Nathanson KL; Hennis A; Nemesure B; Ambs S; Sucheston-Campbell LE; Bensen JT; Chanock SJ; Olshan AF; Ambrosone CB; Olopade OI; Yarney J; Awuah B; Wiafe-Addai B; Conti DV; ; Palmer JR; Garcia-Closas M; Huo D; Haiman CA
J Natl Cancer Inst; 2021 Sep; 113(9):1168-1176. PubMed ID: 33769540
[TBL] [Abstract][Full Text] [Related]
12. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Mavaddat N; Michailidou K; Dennis J; Lush M; Fachal L; Lee A; Tyrer JP; Chen TH; Wang Q; Bolla MK; Yang X; Adank MA; Ahearn T; Aittomäki K; Allen J; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Auer PL; Auvinen P; Barrdahl M; Beane Freeman LE; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bernstein L; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Børresen-Dale AL; Brauch H; Bremer M; Brenner H; Brentnall A; Brock IW; Brooks-Wilson A; Brucker SY; Brüning T; Burwinkel B; Campa D; Carter BD; Castelao JE; Chanock SJ; Chlebowski R; Christiansen H; Clarke CL; Collée JM; Cordina-Duverger E; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dumont M; Durcan L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Ellberg C; Engel C; Eriksson M; Evans DG; Fasching PA; Figueroa J; Fletcher O; Flyger H; Försti A; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Sáenz JA; Gaudet MM; Georgoulias V; Giles GG; Gilyazova IR; Glendon G; Goldberg MS; Goldgar DE; González-Neira A; Grenaker Alnæs GI; Grip M; Gronwald J; Grundy A; Guénel P; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hamann U; Hankinson SE; Harkness EF; Hart SN; He W; Hein A; Heyworth J; Hillemanns P; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huang G; Humphreys K; Hunter DJ; Jakimovska M; Jakubowska A; Janni W; John EM; Johnson N; Jones ME; Jukkola-Vuorinen A; Jung A; Kaaks R; Kaczmarek K; Kataja V; Keeman R; Kerin MJ; Khusnutdinova E; Kiiski JI; Knight JA; Ko YD; Kosma VM; Koutros S; Kristensen VN; Krüger U; Kühl T; Lambrechts D; Le Marchand L; Lee E; Lejbkowicz F; Lilyquist J; Lindblom A; Lindström S; Lissowska J; Lo WY; Loibl S; Long J; Lubiński J; Lux MP; MacInnis RJ; Maishman T; Makalic E; Maleva Kostovska I; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Martinez ME; Mavroudis D; McLean C; Meindl A; Menon U; Middha P; Miller N; Moreno F; Mulligan AM; Mulot C; Muñoz-Garzon VM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen SF; Nordestgaard BG; Norman A; Offit K; Olson JE; Olsson H; Orr N; Pankratz VS; Park-Simon TW; Perez JIA; Pérez-Barrios C; Peterlongo P; Peto J; Pinchev M; Plaseska-Karanfilska D; Polley EC; Prentice R; Presneau N; Prokofyeva D; Purrington K; Pylkäs K; Rack B; Radice P; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Robson M; Romero A; Ruddy KJ; Ruebner M; Saloustros E; Sandler DP; Sawyer EJ; Schmidt DF; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seynaeve C; Shah M; Sherman ME; Shrubsole MJ; Shu XO; Slager S; Smeets A; Sohn C; Soucy P; Southey MC; Spinelli JJ; Stegmaier C; Stone J; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Terry MB; Thöne K; Tollenaar RAEM; Tomlinson I; Truong T; Tzardi M; Ulmer HU; Untch M; Vachon CM; van Veen EM; Vijai J; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett W; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zhang Y; Zheng W; Ziogas A; ; ; ; Dunning AM; Thompson DJ; Chenevix-Trench G; Chang-Claude J; Schmidt MK; Hall P; Milne RL; Pharoah PDP; Antoniou AC; Chatterjee N; Kraft P; García-Closas M; Simard J; Easton DF
Am J Hum Genet; 2019 Jan; 104(1):21-34. PubMed ID: 30554720
[TBL] [Abstract][Full Text] [Related]
13. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
[TBL] [Abstract][Full Text] [Related]
14. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
Ho WK; Tan MM; Mavaddat N; Tai MC; Mariapun S; Li J; Ho PJ; Dennis J; Tyrer JP; Bolla MK; Michailidou K; Wang Q; Kang D; Choi JY; Jamaris S; Shu XO; Yoon SY; Park SK; Kim SW; Shen CY; Yu JC; Tan EY; Chan PMY; Muir K; Lophatananon A; Wu AH; Stram DO; Matsuo K; Ito H; Chan CW; Ngeow J; Yong WS; Lim SH; Lim GH; Kwong A; Chan TL; Tan SM; Seah J; John EM; Kurian AW; Koh WP; Khor CC; Iwasaki M; Yamaji T; Tan KMV; Tan KTB; Spinelli JJ; Aronson KJ; Hasan SN; Rahmat K; Vijayananthan A; Sim X; Pharoah PDP; Zheng W; Dunning AM; Simard J; van Dam RM; Yip CH; Taib NAM; Hartman M; Easton DF; Teo SH; Antoniou AC
Nat Commun; 2020 Jul; 11(1):3833. PubMed ID: 32737321
[TBL] [Abstract][Full Text] [Related]
15. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
16. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
[TBL] [Abstract][Full Text] [Related]
17. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.
Lakeman IMM; Rodríguez-Girondo MDM; Lee A; Celosse N; Braspenning ME; van Engelen K; van de Beek I; van der Hout AH; Gómez García EB; Mensenkamp AR; Ausems MGEM; Hooning MJ; Adank MA; Hollestelle A; Schmidt MK; van Asperen CJ; Devilee P
J Med Genet; 2023 Apr; 60(4):327-336. PubMed ID: 36137616
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
[TBL] [Abstract][Full Text] [Related]
19. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Su L; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2020 Jun; 146(12):3335-3342. PubMed ID: 32037537
[TBL] [Abstract][Full Text] [Related]
20. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
